Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma

doi:10.3748/wjg.v18.i39.5589

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 39

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4185)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

354

HTML

3431

Figures (1-1)

214

Tables (1-2)

186

Sum=4185

Oct 21, 2012 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (61)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Oct 21, 2012; 18(39): 5589-5594
Published online Oct 21, 2012. doi: 10.3748/wjg.v18.i39.5589

Open in New Tab Full Size Figure Download Figure

Figure 1 Kaplan-Meier analysis of metal stent patency rates and overall survival in the photodynamic therapy and control groups. A: Kaplan-Meier analysis of metal stent patency rates. The median stent patency was longer in the photodynamic therapy (PDT) group than in the control group (244 d vs 177 d; P = 0.002); B: Kaplan-Meier analysis of overall survival. The median survival in the PDT group was 356 d, vs 230 d in the stent-only group (P = 0.006). ERBD: Endoscopic retrograde biliary drainage.

Citation: Lee TY, Cheon YK, Shim CS, Cho YD. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. World J Gastroenterol 2012; 18(39): 5589-5594
URL: https://www.wjgnet.com/1007-9327/full/v18/i39/5589.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i39.5589